Mel Mann, 31-year terminal Chronic Myeloid Leukemia (CML) Survivor, Clinical Trial Pioneer, and Patient Advocate, shared on X:
“Doctors gave me 3 years. A clinical trial gave me 31 and counting.
I was 37, terminal CML, no bone marrow match. Gleevec was still experimental. I said yes to the trial because it was my only real shot at tomorrow’s medicine today.
That decision let me watch my daughter grow up and become a doctor. It let me keep living.
Clinical trials aren’t a last resort. They’re often the first real chance at more time.
If you’re facing a diagnosis, ask about them. Your story could be the next one that rewrites the odds.”
Other articles featuring Mel Mann on OncoDaily.